InsiderFlow

Fairmount Funds Management LLC

COGT

Fairmount Funds Management LLC serves as director, 10 percent owner: at Cogent Biosciences, Inc. (COGT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

10 trades

$84.40M

Total Sells

1 trades

$242.62M

Net Position

Net Seller

$158.22M

Companies Traded

4

VRDN, ZBIO, COGT, DNTH

Active Period

Sep 2021 – May 2026

11 total trades

Most Recent

Buy VRDN

May 13, 2026 · $20.00M

Fairmount Funds Management LLC's Insider Trading at Cogent Biosciences, Inc. (COGT)

Buys

0 · $0.00

Sells

1 · $242.62M

Total Shares Bought

0

Total Shares Sold

7,000,000

COGT Price Chart
Loading chart...
DateTypeValue
Mar 31, 2026 Sell$242.62M

Fairmount Funds Management LLC's Insider Trading at Viridian Therapeutics, Inc. (VRDN)

Buys

5 · $80.00M

Sells

0 · $0.00

Total Shares Bought

4,587,191

Total Shares Sold

0

VRDN Price Chart
Loading chart...
DateTypeValue
May 13, 2026 Buy$20.00M
Sep 17, 2024 Buy$30.00M
Jan 24, 2024 Buy$10.00M
Aug 19, 2022 Buy$10.00M
Sep 23, 2021 Buy$10.00M

Fairmount Funds Management LLC's Insider Trading at Zenas BioPharma, Inc. (ZBIO)

Buys

1 · $3.00M

Sells

0 · $0.00

Total Shares Bought

150,000

Total Shares Sold

0

ZBIO Price Chart
Loading chart...
DateTypeValue
Apr 1, 2026 Buy$3.00M

Fairmount Funds Management LLC's Insider Trading at Dianthus Therapeutics, Inc. (DNTH)

Buys

4 · $1.40M

Sells

0 · $0.00

Total Shares Bought

108,924

Total Shares Sold

0

DNTH Price Chart
Loading chart...
DateTypeValue
Oct 3, 2023 Buy$336.3K
Sep 28, 2023 Buy$394.5K
Sep 21, 2023 Buy$396.0K
Sep 13, 2023 Buy$271.7K